Search results for "Coronavirus"
Third shot for immunocompromised patients, ACP and others urge vaccine in pregnancy, more COVID-19 news
The FDA and multiple new studies supported a third vaccine dose for organ transplant patients, an ACP statement and an observational trial highlighted benefits of vaccination during pregnancy, and a randomized trial found benefit from budesonide in high-risk outpatients with COVID-19.
https://immattersacp.org/weekly/archives/2021/08/17/1.htm
17 Aug 2021
Explore new content, enhanced search functionality on ACP's Online Learning Center
The Online Learning Center is a centralized gateway to more than 350 online learning activities that are CME and MOC eligible, many of which are free to ACP members.
https://immattersacp.org/weekly/archives/2020/02/25/6.htm
25 Feb 2020
CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness
Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
https://immattersacp.org/weekly/archives/2021/09/28/1.htm
28 Sep 2021
New EUA and dose guidelines for COVID-19 released, ACIP reviewed myocarditis reports
The FDA gave an emergency use authorization (EUA) to tocilizumab for inpatients, the NIH revised dosing recommendations on monoclonal antibodies for outpatients, and government experts said myocarditis is extremely rare with the vaccines, among other recent COVID-19 news.
https://immattersacp.org/weekly/archives/2021/06/29/1.htm
29 Jun 2021
COVID-19 outcomes in health care workers and over the long term, vaccine evidence and uptake among the latest research
A study found that health care workers hospitalized with COVID-19 had shorter stays, while a survey showed high uncertainty about vaccination. Johnson & Johnson released efficacy data on a one-shot vaccine, and a study identified long-term decreases in function among COVID-19 survivors.
https://immattersacp.org/weekly/archives/2021/02/02/1.htm
2 Feb 2021
Latest research looks at prolonged symptoms, drug treatments in COVID-19
Two studies found symptoms to be common months to a year after COVID-19 infection, while other research found benefits from interleukin-6 inhibitors but no significant effects of ivermectin, remdesivir, and hydroxychloroquine.
https://immattersacp.org/weekly/archives/2021/07/13/1.htm
13 Jul 2021
Q&A: Dealing with COVID-19 vaccine allocation, distribution
The new availability of vaccines has highlighted the challenges of allocation and distribution, which were the focus of a recent forum hosted by ACP and Annals of Internal Medicine.
https://immattersacp.org/weekly/archives/2021/02/02/2.htm
2 Feb 2021
ACP issues guidance on easing social distancing, recognizes role of internists during the pandemic
The College addressed what communities need to safely resume economic activities and in-person medical visits, and released a new video emphasizing the essential role of the internal medicine community.
https://immattersacp.org/weekly/archives/2020/05/12/2.htm
12 May 2020
Antibody therapy gets EUA, studies show pandemic's effects on emergency care
Sotrovimab received an emergency use authorization (EUA) for some high-risk outpatients with COVID-19, and multiple studies found changed patterns in cardiac emergencies and care associated with the pandemic.
https://immattersacp.org/weekly/archives/2021/06/08/1.htm
8 Jun 2021
COVID-19 research focused on anticoagulation, vaccine-induced thrombocytopenia
Two new studies support prophylactic, rather than therapeutic, anticoagulation for COVID-19 patients, and case reports provide more information about vaccine-induced immune thrombotic thrombocytopenia.
https://immattersacp.org/weekly/archives/2021/06/15/1.htm
15 Jun 2021